Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.17%)
As of: Sep 4, 2026 · 3:19 PM EDT

Compugen (CGEN) Assets Growth (1y) (2010 - 2026)

Analysis

Compugen (CGEN) Assets Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Compugen 241.50 Mn 155.89 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.89%
Mar 31, 2026 26.35%
Dec 31, 2025 36.15%
Sep 30, 2025 -20.78%
Jun 30, 2025 -3.31%
Mar 31, 2025 1.53%
Dec 31, 2024 -5.22%
Sep 30, 2024 82.69%
Jun 30, 2024 42.97%
Mar 31, 2024 34.85%
Dec 31, 2023 28.84%
Sep 30, 2023 -31.96%
Jun 30, 2023 -30.15%
Mar 31, 2023 -30.28%
Dec 31, 2022 -28.74%
Sep 30, 2022 -18.08%
Jun 30, 2022 -10.18%
Mar 31, 2022 -6.96%
Dec 31, 2021 -4.45%
Sep 30, 2021 -15.39%